Skip to content
Screener

Teleflex TFX Investing Cash Flow

Investing Cash Flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$241M+28.3%
Haemonetics logo
HaemoneticsHAE
-$22.23M+32.6%
Utah Medical Products logo
Utah Medical ProductsUTMD
-$130K+29.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.73M+126%
ICU Medical logo
ICU MedicalICUI
-$20.14M-111%
Boston Scientific logo
Boston ScientificBSX
-$591M-18.2%

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$6.15B+24.1%
Enterprise value$8.81B+31.7%
P/S2.7×-0.1×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 29, 2025
Insurance settlement proceeds9,447
Net payments on swaps designated as net investment hedges(39,542)7,612
Purchase of investments(9,000)(5,000)
Net cash used in investing activities from continuing operations(81,367)(46,562)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings2,350,000300,000
Reduction in borrowings(2,175,000)(55,375)
Repurchase of common stock(250,000)(300,000)

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's investing cash flow?
Teleflex (TFX) reported investing cash flow of -$6.58M in Q2 2026.
How has Teleflex's investing cash flow changed year-over-year?
Teleflex's investing cash flow increased by 78.4% year-over-year, from -$30.49M to -$6.58M.
What is the long-term trend for Teleflex's investing cash flow?
Over 4 years (2021 to 2025), Teleflex's investing cash flow has grown at a 49.0% compound annual growth rate (CAGR), from $167.73M to -$826.78M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Teleflex's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude